Publicaciones en colaboración con investigadores/as de Hospital General Universitario Gregorio Marañón (21)

2022

  1. Children living with HIV in Europe: do migrants have worse treatment outcomes?

    HIV Medicine, Vol. 23, Núm. 2, pp. 186-196

2020

  1. Executive Summary of the Consensus Document on the Diagnosis and Management of Patients with Primary Immunodeficiencies

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 38, Núm. 9, pp. 438-443

  2. Executive Summary of the Consensus Document on the Diagnosis and Management of Patients with Primary Immunodeficiencies

    Journal of Allergy and Clinical Immunology: In Practice, Vol. 8, Núm. 10, pp. 3342-3347

  3. Virological outcome among HIV infected patients transferred from pediatric care to adult units in Madrid, Spain (1997–2017)

    Scientific Reports, Vol. 10, Núm. 1

2016

  1. Off-label use of rilpivirine in combination with emtricitabine and tenofovir in HIV-1-infected pediatric patients A multicenter study

    Medicine (United States), Vol. 95, Núm. 24

  2. Tolerancia y eficacia de una formula extensamente hidrolizada en lactantes con alergia a proteínas de leche de vaca mediada por IgE. Estudio JUNGLO (I): Hidrolizado extenso de caseína

    Acta Pediatrica Espanola, Vol. 74, Núm. 3-4, pp. 83-90

2015

  1. Lack of association between JAK3 gene polymorphisms and cardiovascular disease in Spanish patients with rheumatoid arthritis

    BioMed Research International, Vol. 2015

  2. Visual screening (Part 2)

    Pediatria de Atencion Primaria, Vol. 17, Núm. 65, pp. e57-e67

2014

  1. Interferon regulatory factor 5 genetic variants are associated with cardiovascular disease in patients with rheumatoid arthritis

    Arthritis Research and Therapy, Vol. 16, Núm. 4

  2. Lack of association between ABO, PPAP2B, ADAMST7, PIK3CG, and EDNRA and carotid intima-media thickness, carotid plaques, and cardiovascular disease in patients with rheumatoid arthritis

    Mediators of Inflammation, Vol. 2014

  3. Osteoprotegerin CGA haplotype protection against cerebrovascular complications in anti-CCP negative patients with rheumatoid arthritis

    PLoS ONE, Vol. 9, Núm. 9

2013

  1. Single-nucleotide polymorphisms at the 9p21.3 genomic region not associated with the risk of cardiovascular disease in patients with rheumatoid arthritis

    Tissue Antigens, Vol. 82, Núm. 6, pp. 405-409

  2. The 11q23.3 genomic region-rs964184-is associated with cardiovascular disease in patients with rheumatoid arthritis

    Tissue Antigens, Vol. 82, Núm. 5, pp. 344-347

2010

  1. Efectividad de palivizumab en la prevención de la infección por el virus respiratorio sincitial en prematuros de 321 a 35° semanas de gestación en España

    Acta Pediatrica Espanola, Vol. 68, Núm. 1, pp. 13-18

  2. The genomics serving pediatrics in the investigation of the multifactorial disease

    Acta Pediatrica Espanola, Vol. 68, Núm. 2, pp. 55-60

2009

  1. Recomendaciones para el cuidado y atención del recién nacido sano en el parto y en las primeras horas después del nacimiento

    Anales de Pediatria, Vol. 71, Núm. 4, pp. 349-361

  2. Retinopathy of prematurity. Prevention, screening and treatment guidelines

    Anales de Pediatria, Vol. 71, Núm. 6, pp. 514-523

2007

  1. Evaluation of procalcitonin for diagnosis of neonatal sepsis of vertical transmission

    BMC Pediatrics, Vol. 7

2006

  1. Procalcitonin is not sufficiently reliable to be the sole marker of neonatal sepsis of nosocomial origin

    BMC Pediatrics, Vol. 6

2005

  1. Trends in the epidemiology of neonatal sepsis of vertical transmission in the era of group B streptococcal prevention

    Acta Paediatrica, International Journal of Paediatrics, Vol. 94, Núm. 4, pp. 451-457